295 related articles for article (PubMed ID: 12369210)
21. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
22. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias.
Katritsis DG; Siontis GC; Camm AJ
Prog Cardiovasc Dis; 2013; 56(2):133-42. PubMed ID: 24215745
[TBL] [Abstract][Full Text] [Related]
24. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
27. QT dynamics and the risk of sudden arrhythmic cardiac death in ischemic heart disease.
Sredniawa B; Jarski P; Musialik-Lydka A; Kalarus Z; Polonski L
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):827-8. PubMed ID: 15189545
[TBL] [Abstract][Full Text] [Related]
28. Intrathoracic far-field electrocardiogram allows continuous monitoring of ischemia after total coronary occlusion.
Asbach S; Weiss I; Wenzel B; Bode C; Zehender M
Pacing Clin Electrophysiol; 2006 Dec; 29(12):1334-40. PubMed ID: 17201839
[TBL] [Abstract][Full Text] [Related]
29. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
30. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
[TBL] [Abstract][Full Text] [Related]
31. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
32. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
34. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
35. Real-time assessment of acute myocardial ischaemia by an intra-thoracic 6-lead ECG: evaluation of a new diagnostic option in the implantable defibrillator.
Baron TW; Faber TS; Grom A; Schwab T; Brunner M; Geibel A; Just H; Bode C; Zehender M
Europace; 2006 Nov; 8(11):994-1001. PubMed ID: 17005592
[TBL] [Abstract][Full Text] [Related]
36. ICD therapy in coronary artery disease. A reappraisal in 2005.
Grönefeld G; Manegold J; Israel CW; Hohnloser SH
Herz; 2005 Mar; 30(2):82-6. PubMed ID: 15875095
[TBL] [Abstract][Full Text] [Related]
37. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aims.
Grönefeld G; Connolly SJ; Hohnloser SH;
Card Electrophysiol Rev; 2003 Dec; 7(4):447-51. PubMed ID: 15071273
[TBL] [Abstract][Full Text] [Related]
38. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
39. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
40. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]